BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27470341)

  • 1. Artesunate obliterates experimental hepatocellular carcinoma in rats through suppression of IL-6-JAK-STAT signalling.
    Ilamathi M; Prabu PC; Ayyappa KA; Sivaramakrishnan V
    Biomed Pharmacother; 2016 Aug; 82():72-9. PubMed ID: 27470341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formylchromone exhibits salubrious effects against nitrosodiethylamine mediated early hepatocellular carcinogenesis in rats.
    Ilamathi M; Senthilkumar S; Prabu PC; Panchapakesan S; Sivaramakrishnan V
    Chem Biol Interact; 2014 Aug; 219():175-83. PubMed ID: 24954034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artesunate as an Anti-Cancer Agent Targets Stat-3 and Favorably Suppresses Hepatocellular Carcinoma.
    Ilamathi M; Santhosh S; Sivaramakrishnan V
    Curr Top Med Chem; 2016; 16(22):2453-63. PubMed ID: 26873192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NDP-α-MSH attenuates heart and liver responses to myocardial reperfusion via the vagus nerve and JAK/ERK/STAT signaling.
    Ottani A; Giuliani D; Neri L; Calevro A; Canalini F; Vandini E; Cainazzo MM; Ruberto IA; Barbieri A; Rossi R; Guarini S
    Eur J Pharmacol; 2015 Dec; 769():22-32. PubMed ID: 26477637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-Morin.
    Sivaramakrishnan V; Shilpa PN; Praveen Kumar VR; Niranjali Devaraj S
    Chem Biol Interact; 2008 Jan; 171(1):79-88. PubMed ID: 17950263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of chemopreventive effect of Fumaria indica against N-nitrosodiethylamine and CCl4-induced hepatocellular carcinoma in Wistar rats.
    Hussain T; Siddiqui HH; Fareed S; Vijayakumar M; Rao CV
    Asian Pac J Trop Med; 2012 Aug; 5(8):623-9. PubMed ID: 22840450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats.
    Khan MS; Devaraj H; Devaraj N
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):85-94. PubMed ID: 21167192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ellagic Acid Holds Promise Against Hepatocellular Carcinoma in an Experimental Model: Mechanisms of Action.
    Zaazaa AM; Lokman MS; Shalby AB; Ahmed HH; El-Toumy SA
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):387-393. PubMed ID: 29479987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citral inhibits N-nitrosodiethylamine-induced hepatocellular carcinoma via modulation of antioxidants and xenobiotic-metabolizing enzymes.
    Krishnan P; Sundaram J; Salam S; Subramaniam N; Mari A; Balaraman G; Thiruvengadam D
    Environ Toxicol; 2020 Sep; 35(9):971-981. PubMed ID: 32302048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.
    Liao J; Xu T; Zheng JX; Lin JM; Cai QY; Yu DB; Peng J
    Int J Mol Med; 2013 Jul; 32(1):79-84. PubMed ID: 23613111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepato-protective effect of rutin via IL-6/STAT3 pathway in CCl4-induced hepatotoxicity in rats.
    Hafez MM; Al-Harbi NO; Al-Hoshani AR; Al-Hosaini KA; Al Shrari SD; Al Rejaie SS; Sayed-Ahmed MM; Al-Shabanah OA
    Biol Res; 2015 Jun; 48(1):30. PubMed ID: 26062544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longer warm ischemia can accelerate tumor growth through the induction of HIF-1α and the IL-6-JAK-STAT3 signaling pathway in a rat hepatocellular carcinoma model.
    Hamaguchi Y; Mori A; Fujimoto Y; Ito T; Iida T; Yagi S; Okajima H; Kaido T; Uemoto S
    J Hepatobiliary Pancreat Sci; 2016 Dec; 23(12):771-779. PubMed ID: 27734596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymoquinone inhibits cell proliferation through regulation of G1/S phase cell cycle transition in N-nitrosodiethylamine-induced experimental rat hepatocellular carcinoma.
    Raghunandhakumar S; Paramasivam A; Senthilraja S; Naveenkumar C; Asokkumar S; Binuclara J; Jagan S; Anandakumar P; Devaki T
    Toxicol Lett; 2013 Oct; 223(1):60-72. PubMed ID: 24012840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
    Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D
    Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro.
    Wilson GS; Tian A; Hebbard L; Duan W; George J; Li X; Qiao L
    Cancer Lett; 2013 Dec; 341(2):224-30. PubMed ID: 23941832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Effects of Total Glucosides of Paeony on N-nitrosodiethylamine-induced Hepatocellular Carcinoma in Rats via Down-regulation of Regulatory B Cells.
    Song SS; Yuan PF; Li PP; Wu HX; Ni WJ; Lu JT; Wei W
    Immunol Invest; 2015; 44(6):521-35. PubMed ID: 26207789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells.
    Fuke H; Shiraki K; Sugimoto K; Tanaka J; Beppu T; Yoneda K; Yamamoto N; Ito K; Masuya M; Takei Y
    Biochem Biophys Res Commun; 2007 Nov; 363(3):738-44. PubMed ID: 17904524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5H-benzo[h]thiazolo[2,3-b]quinazolines ameliorate NDEA-induced hepatocellular carcinogenesis in rats through IL-6 downregulation along with oxidative and metabolic stress reduction.
    Keshari AK; Singh AK; Kumar U; Raj V; Rai A; Kumar P; Kumar D; Maity B; Nath S; Prakash A; Saha S
    Drug Des Devel Ther; 2017; 11():2981-2995. PubMed ID: 29075102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on correlation of JAK/STAT signal pathway with progression and prognosis in hepatocellular carcinoma].
    Zhang B; Zhong DW; Wang QW; Miao XY; Dai WD; Liu C; Pan KH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Apr; 26(4):368-70, 373. PubMed ID: 20368117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from in vivo study.
    Aglan HA; Ahmed HH; El-Toumy SA; Mahmoud NS
    Tumour Biol; 2017 Jun; 39(6):1010428317699127. PubMed ID: 28618930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.